Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05242484
Other study ID # CR109179
Secondary ID 78934804UCO20012
Status Recruiting
Phase Phase 2
First received
Last updated
Start date September 19, 2022
Est. completion date March 27, 2029

Study information

Verified date June 2024
Source Janssen Research & Development, LLC
Contact Study Contact
Phone 844-434-4210
Email Participate-In-This-Study@its.jnj.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab in participants with moderately to severely active ulcerative colitis who have had an inadequate initial response, loss of response, or intolerance to one or more approved advanced therapy.


Recruitment information / eligibility

Status Recruiting
Enrollment 550
Est. completion date March 27, 2029
Est. primary completion date May 27, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Confirmed diagnosis of ulcerative colitis (UC) for at least 3 months prior to baseline - Moderately to severely active UC as assessed by the modified Mayo Score - Demonstrated inadequate response, loss of response, or intolerance to at least one biologic or novel oral with biologic-like activity - If female and of childbearing potential, must meet the contraception and reproduction requirements Exclusion Criteria: - Has severe extensive colitis as defined in the protocol - Extent of inflammatory disease limited to the rectum - Participants with current diagnosis of indeterminate colitis, microscopic colitis, ischemic colitis, or Crohn's disease (CD) - Has a history of, or ongoing, chronic or recurrent infectious disease, including but not limited to, sinopulmonary infections, bronchiectasis, recurrent renal/urinary tract infections (example, pyelonephritis, cystitis), an open, draining, or infected skin wound, or an ulcer - Currently has a malignancy or a history of malignancy within 5 years before screening (with the exception of nonmelanoma skin cancer or cervical carcinoma in situ that has been treated with no evidence of recurrence within 12 months of first dose of study intervention)

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Guselkumab
Guselkumab will be administered as subcutaneous injection.
Golimumab
Golimumab will be administered as subcutaneous injection.
JNJ-78934804
JNJ-78934804 will be administered subcutaneously as per defined regimen.
Drug:
Placebo
Placebo will be administered as subcutaneous injection.

Locations

Country Name City State
Argentina Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo Ciudad Autonoma Buenos Aires
Argentina CIPREC Ciudad Autonoma de Buenos Aires
Argentina Hospital Britanico de Buenos Aires Ciudad Autonoma de Buenos Aires
Argentina Sanatorio Duarte Quiroz Cordoba
Argentina Centro de Investigaciones Medicas Mar Del Plata Mar Del Plata
Argentina Hospital Provincial del Centenario Rosario
Australia Box Hill Hospital Box Hill
Australia Royal Prince Alfred Hospital Camperdown
Australia Monash Health, Monash Medical Centre Clayton
Australia Concord Hospital Concord
Australia Western Health Footscray
Australia Coastal Digestive Health Maroochydore
Australia Fiona Stanley Hospital Murdoch
Australia Royal Adelaide Hospital North Terrace
Australia Royal Melbourne Hospital Parkville
Australia The Alfred Hospital Prahran
Australia Mater Hospital Brisbane South Brisbane
Austria Universitaetsklinikum Salzburg Landeskrankenhaus Salzburg
Austria Klinikum Wels Grieskirchen Wels
Austria Krankenhaus der Barmherzigen Brüder Wien
Austria Medizinische Universitat Wien Wien
Belgium Imelda Ziekenhuis Bonheiden
Belgium Algemeen Ziekenhuis Sint-Jan Brugge
Belgium Cliniques Universitaires Saint Luc Bruxelles
Belgium AZ Maria Middelares Gent
Belgium UZ Gent Gent
Belgium UZ Leuven Leuven
Belgium CHU de Liege Liege
Belgium CHC MontLegia Liège
Belgium Vitaz Sint-Niklaas
Brazil Universidade Estadual Paulista 'Julio De Mesquita Filho' Botucatu
Brazil Chronos Clinica Medica LTDA - Chronos Pesquisa Clinica Brasilia
Brazil L2IP Instituto de Pesquisas Clinicas Brasilia
Brazil Fundacao Universidade de Caxias do Sul Caxias Do Sul
Brazil Centro Digestivo de Curitiba - Instituto de Pesquisa Clínica Curitiba
Brazil Associacao Hospitalar Moinhos de Vento Porto Alegre
Brazil Hospital das Clinicas de Porto Alegre Porto Alegre
Brazil Hospital de Clinicas de Porto Alegre Porto Alegre
Brazil Universidade Federal do Rio de Janeiro - Faculdade de Medicina Rio de Janeiro
Brazil SER - Servicos Especializados em Reumatologia da Bahia Salvador
Brazil Pesquisare Saude Santo Andre
Brazil Irmandade da Santa Casa da Misericórdia de Santos Santos
Brazil BR Trials Sao Paulo
Brazil Instituto de Assistencia Medica ao Servidor Publico Estadual IAMSPE Sao Paulo
Brazil Instituto D Or de Pesquisa e Ensino (IDOR) São Paulo
Bulgaria Medical Centre Hipocrat Haskovo
Bulgaria Diagnostic Consulting Center I Sliven Sliven
Bulgaria UMHAT 'Tsaritsa Yoanna' Sofia
Bulgaria University Hospital Alexandrovska - Clinic of Nephrology Sofia-Grad
Bulgaria Medical Center -Medika Plus Veliko Tarnovo
Bulgaria Multriprofile Hospital for Active Treatment Hristo Botev Vratsa
Canada Viable Clinical Research Bridgewater
Canada Foothills Hospital Calgary Alberta
Canada Viable Clinical Research Dartmouth Nova Scotia
Canada Covenant Health/Grey Nuns hospital Edmonton Alberta
Canada Gastroenterology and Internal Medicine Research Institute (GIRI) Edmonton Alberta
Canada Nova Scotia Health Authority Halifax Nova Scotia
Canada London Health Sciences Centre - University Campus London Ontario
Canada CMIIM, Centre médical L'Enjeu Mont-Royal Quebec
Canada CIUSSS de l'Est-de-l'Île-de-Montréal Installation Hôpital Maisonneuve-Rosemont Montreal Quebec
Canada McGill University - Health Centre - Montreal General Hospital Montreal Quebec
Canada Columbia Gastroenterology New Westminster British Columbia
Canada Hopital Chicoutimi Saguenay
Canada St. Jerome Medical Research Saint-Jerome Quebec
Canada Toronto Immune & Digestive Health Institute Inc. Toronto Ontario
Canada GIRI Gastrointestinal Research Institute Vancouver British Columbia
Canada The Gordon & Leslie Diamond Health Care Center Vancouver British Columbia
Canada PerCuro Clinical Research Ltd. Victoria British Columbia
Canada Health Sciences Centre Winnipeg Manitoba
Chile Hospital Clinico Regional Dr. Guillermo Grant Benavente Concepcion
Chile Centro de Estudios Clínicos e Investigación Médica (CeCim) Santiago
Chile Clinica Dermacross S A Santiago
Chile Complejo Asistencial Hospital Dr. Sótero del Río Santiago
China China Japan Friendship Hospital Chaoyang
China West China Hospital Sichuan University Chengdu
China Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou
China Jinhua municipal central hospital Jinhua
China Zhongda Hospital Southeast University Nanjing
China Union Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan
Croatia Opca bolnica Bjelovar Bjelovar
Croatia University Hospital Center Split Split
Croatia University Hospital Dubrava Zagreb
Czechia Vojenska nemocnice Brno Brno
Czechia ISCARE a.s. Praha 9
Denmark Aalborg Hospital Aalborg
Denmark Aarhus University Hospital Aarhus
Denmark Bispebjerg Og Frederiksberg Hospital Copenhagen
Denmark Herlev Hospital, University of Copenhagen Herlev
Denmark Odense Universitetshospital Odense
Estonia East Tallinn Central Hospital Tallinn
Estonia West Tallinn Central Hospital Tallinn
Estonia Tartu University Hospital Tartu
France CHU Amiens - Hopital Sud AMIENS cedex 1
France Hopital Louis Mourier Colombes Cedex
France Centre Hospitalier Universitaire(CHU) - Hopital Henri Mondor Créteil
France CHU Grenoble Grenoble
France Centre Hospitalier Départemental VENDEE La Roche sur Yon
France CHRU de Lille Hopital Claude Huriez Lille
France Hopital Nord Marseille Marseille
France Hopital Saint Eloi Montpellier
France Clinique Ambroise Pare Neuilly-sur-Seine
France CHU de Nice Hopital de l Archet Nice cedex 03
France CHU Nimes Hopital Caremeau Nîmes
France Hopital Haut-Leveque, CMC Magellan Pessac
France Hospices Civils de Lyon HCL Pierre Bénite
France CHU Saint-etienne Saint Etienne
France Hopital de Rangueil Toulouse cedex 09
France CHRU Nancy Brabois Vandoeuvre les Nancy
Germany Charite - Universitaetsmedizin Berlin (CCM) Berlin
Germany Charite Universitaetsmedizin Berlin - Campus Charite Mitte Berlin
Germany Krankenhaus Waldfriede Mitte Berlin
Germany Praxis Für Gastroenteroligie Berlin
Germany Gastroenterologische Spezialpraxis - Berlin-Karlshorst Berlin-Karlshorst
Germany University Hospital Dresden Dresden
Germany Universitaetsklinik Erlangen Erlangen
Germany JWG-University Hospital Frankfurt
Germany Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus Frankfurt/Main
Germany Universitatsklinikum Freiburg Freiburg
Germany Klinikum Fulda - Tumorklinik - Germany Fulda
Germany BSF Studiengesellschaft Halle
Germany Martin-Luther-Universitaet Halle-Wittenberg - Universitaetsk Halle (Saale)
Germany Medizinische Hochschule Hannover Hannover
Germany Gastroenterology Outpatient Clinic Prof. Ehehalt/Dr. Hemstäd Heidelberg
Germany University Hospital Heidelberg Heidelberg
Germany Universitatsklinikum Jena Jena
Germany Praxisgemeinschaft Jerichow Jerichow
Germany Eugastro GmbH Leipzig
Germany Staedtisches Klinikum Lueneburg Lueneburg
Germany Universitaetsklinikum Mannheim Mannheim
Germany Gastroenterologische Gemeinschaftspraxis Minden Minden
Germany Klinikum der Universitaet Muenchen Munich
Germany Praxis fur Innere Medizin und Gastroenterologie Munster
Germany MVZ Portal 10 Münster
Germany Medius Klinik Nürtingen Nürtingen
Germany Siloah St Trudpert Klinikum Pforzheim
Germany Zentrum für Gastroenterologie Saar MVZ GmbH Saarbrücken
Germany Universitaetsklinik Tuebingen Tübingen
Germany Universitatsklinikum Ulm Ulm
Germany Gemeinschaftspraxis Jakobeit Wipperfürth
Germany Universitatsklinikum Wurzburg Würzburg
Greece Alexandra General Hospital of Athens Athens
Greece Sotiria General State Hospital of Chest Diseases Athens
Greece Nikaia General Hospital Piraievs
Greece Hippokration Hospital Thessaloniki
Hungary Magyar Honvedseg Egeszsegugyi Kozpont Budapest
Hungary Obudai Egeszsegugyi Centrum Kft Budapest
Hungary Pannónia Magánorvosi Centrum Kft Budapest
Hungary Semmelweis Egyetem Budapest
Hungary Bugat Pal Korhaz Gyongyos
Hungary Szegedi Tud Egyetem Szent Gyorgyi Albert Klin Kozp Szeged
Hungary Markusovszky Egyetemi Oktatokorhaz Szombathely
India M S Ramaiah Medical College and Hospital Bangalore
India Siksha O Anusandhan University - Institute of Medical Scienc Bhubaneswar
India Apex Hospitals Ltd Jaipur
India All India Institute of Medical Sciences New Delhi
India Fortis Hospital New Delhi
India Sir Ganga Ram Hospital New Delhi
India Yashoda Super Speciality Hospitals Secunderabad
India Surat Institute of Digestive Sciences Hospitals Surat
Israel Haemek Medical Center - Afula Afula
Israel Bnai Zion Medical Center Haifa
Israel Rambam Medical Center Haifa
Israel Hadassah Hebrew University Medical Center Jerusalem
Israel Shaare Zedek Medical Center Jerusalem
Israel Rabin Medical Center Beilinson Campus Petah Tikva
Israel Kaplan Medical Center Rehovot
Israel Tel Aviv Sourasky Medical Center Tel Aviv Yafo
Israel The Chaim Sheba Medical Center Tel Hashomer
Israel Assaf Harofeh Medical Center Tzrifin
Italy Università degli Studi di Bari Bari
Italy A.O. Per L' Emergenza Cannizzaro - U.O. Chirurgia Generale Catania
Italy AOU Policlinico G.Martino Messina
Italy Ospedale San Raffaele HSR Istituto Scientifico Universitario San Raffaele Milano
Italy Azienda Ospedaliero Universitaria di Cagliari - Policlinico Duilio Casula di Monserrato Monserrato
Italy Azienda Ospedaliera San Gerardo Monza
Italy Ospedale Sacro Cuore Don Calabria Negrar Di Valpolicella
Italy Ospedale Villa Sofia-Cervello Palermo
Italy Policlinico Universitario Agostino Gemelli Roma
Italy Università Campus Biomedico di Roma Roma
Italy IRCCS Humanitas Rozzano-IBD Center Malattie Infiammatorie Croniche Intestinali Rozzano
Italy Casa Sollievo della Sofferenza San Giovanni Rotondo
Japan Asahikawa Medical University Hospital Asahikawa
Japan Tokyo Medical and Dental University Hospital Bunkyo Ku
Japan Fukuoka University Chikushi Hospital Chikushino
Japan Kitakyushu Municipal Medical Center Fukuoka-ken
Japan Gifu Prefectural General Medical Center Gifu
Japan Tokai University Hachioji Hospital Hachioji
Japan Hamamatsu University Hospital Hamamatsu
Japan Hirosaki University Hospital Hirosaki
Japan National Hospital Organization Hirosaki General Medical Center Hirosaki
Japan Tokai University Hospital Isehara
Japan Kagoshima IBD Gastroenterology Clinic Kagoshima
Japan Kagoshima University Hospital Kagoshima
Japan Ofuna Chuo Hospital Kamakura
Japan Matsushima Clinic Kanagawa
Japan Nara Medical University Hospital Kashihara
Japan Tsujinaka Hospital Kashiwanoha Kashiwa
Japan Kobe University Hospital Kobe
Japan Yamanashi Prefectural Central Hospital Kofu-Shi
Japan Kumamoto University Hospital Kumamoto
Japan Kurume University Hospital Kurume
Japan Kyoto University Hospital Kyoto
Japan University Hospital Kyoto Perfectural University of Medicine Kyoto
Japan Gunma University Hospital Maebashi
Japan Kitasato University Kitasato Institute Hospital Minato-ku
Japan Kyorin University Hospital Mitaka
Japan Iwate Medical University Hospital Morioka
Japan Nagoya City University Hospital Nagoya
Japan Nagoya University Hospital Nagoya
Japan The Hospital of Hyogo College of Medicine Nishinomiya
Japan Ogaki Municipal Hospital Ogaki
Japan Oita Red Cross Hospital Oita
Japan Japan Community Health Care Organization Osaka Hospital Osaka
Japan Kinshukai Infusion Clinic Osaka
Japan Osaka City University Hospital Osaka
Japan National Hospital Organization Osaka National Hospital Osaka-shi
Japan Toho University Sakura Medical Center Sakura
Japan Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital Sapporo
Japan Sapporo Higashi Tokushukai Hospital Sapporo
Japan Sapporo Tokushukai Hospital Sapporo
Japan Sapporo IBD Clinic Sapporo Chuo-ku
Japan Tokyo Metropolitan Bokutoh Hospital Sumida ku
Japan National Hospital Organization Tokyo Medical Center Tokyo
Japan The Jikei University Hospital Tokyo
Japan Tokyo Medical University Hospital Tokyo
Japan Tokyo Saiseikai Central Hospital Tokyo
Japan Oji General Hospital Tomakomai
Japan Toyama Prefectural Central Hospital Toyama
Japan Toyota Kosei Hospital Toyota
Japan Mie University Hospital Tsu
Japan University of Tsukuba Hospital Tsukuba City
Japan Wakayama Medical University Hospital Wakayama
Japan Yokohama City University Medical Center Yokohama
Jordan Istishari Hospital Amman
Jordan Jordan University Hospital Amman
Jordan Irbid Specialty Hospital Irbid
Jordan King Abdullah University Hospital Irbid
Korea, Republic of Inje University Haeundae Paik Hospital Busan
Korea, Republic of Kosin University Gospel Hospital Busan
Korea, Republic of Yeungnam University Hospital Daegu
Korea, Republic of Chosun university hospital Gwangju
Korea, Republic of The Catholic university of Korea, St. Vincent's Hospital Gyeonggi-do
Korea, Republic of Hallym University Dongtan Sacred Heart Hospital Hwaseong-si
Korea, Republic of Asan Medical Center Seoul
Korea, Republic of Gangnam Severance Hospital, Yonsei University Health System Seoul
Korea, Republic of Kangbuk Samsung Hospital Seoul
Korea, Republic of Kyung Hee University Hospital Seoul
Korea, Republic of Severance Hospital Yonsei University Health System Seoul
Korea, Republic of The Catholic University of Korea Seoul St.Mary's Hospital Seoul
Korea, Republic of The Catholic University of Korea Seoul St.Mary's Hospital Seoul
Korea, Republic of Ajou University Hospital Suwon
Korea, Republic of Yonsei University Wonju Severance Christian Hospital Wonju, Gangwon-do
Netherlands Academisch Medisch Centrum Universiteit van Amsterdam Amsterdam
Netherlands Albert Schweitzer Ziekenhuis Dordrecht
Netherlands Maastricht University Medical Centre Maastricht
Netherlands Erasmus Medisch Centrum Rotterdam
Netherlands UMC Utrecht Utrecht
New Zealand Christchurch Hospital Christchurch
New Zealand Dunedin Hospital Dunedin
New Zealand Hutt Hospital Lower Hutt
New Zealand Wellington Hospital Wellington
Norway Alesund sjukehus Alesund
Norway Vestre Viken HF Baerum Sykehus Gjettum
Norway Sykehuset Immlandet HF Gjøvik Gjøvik
Norway Akershus Universitetssykehus Lørenskog
Norway Oslo University Hospital HF Ulleval sykehus Oslo
Norway Universitetssykehuset Nord-Norge HF Tromso
Poland Szpital Uniwersytecki No2 Bydgoszcz
Poland Centrum Medyczne Plejady Krakow
Poland Centrum Medyczne Promed Krakow
Poland AmiCare Centrum Medyczne Lodz
Poland ETG Lublin Lublin
Poland Gastromed Spotka Z Ograniczona Odpowiedzialnoscia Sp. K. Lublin
Poland Allmedica Nowy Targ
Poland Wojewodzki Szpital Specjalistyczny w Olsztynie Olsztyn
Poland Synexus Polska Sp. z o.o. Poznan
Poland Twoja Przychodnia Poznan
Poland Centrum Medyczne Medyk Rzeszow
Poland Endoskopia Sp z o.o. Sopot
Poland Sonomed Sp. z o.o. Szczecin
Poland Twoja Przychodnia - Szczecinskie Centrum Medyczne Szczecin
Poland GASTROMED Sp. z o.o. Torun
Poland Centralny Szpital Kliniczny Mswia Warszawa
Poland Centrum Zdrowia Matki, Dziecka i Mlodziezy Warszawa
Poland NZOZ Vivamed Warszawa
Poland Reumatika-Centrum Reumatologii, NZOZ Warszawa
Poland Wojskowy Instytut Medyczny Warszawa
Poland Centrum Diagnostyczno - Lecznicze Barska sp. z o.o. Szpital Specjalistyczny Barska Wloclawek
Poland Centrum Medyczne Oporow Wroclaw
Poland EuroMediCare Szpital Specjalistyczny z Przychodnia Wroclaw
Poland Melita Medical Sp. z o.o. Wroclaw
Poland Przychodnia Vistamed Wroclaw
Poland ETG Zamosc Zamosc
Portugal Centro Hospitalar de Lisboa Norte Hospital Santa Maria Lisboa
Portugal Hospital Beatriz Angelo Loures
Portugal Hospital de Portimao-Centro Hospitalar do Barlavento Algarvio Portimao
Portugal Centro Hospitalar de Entre o Douro e Vouga, E.P.E Santa Maria da Feira
Portugal Chvng Unidade I Vila Nova de Gaia
Slovakia FNsP F.D.R. Banska Bystrica Banska Bystrica
Slovakia Cliniq s.r.o. Bratislava
Slovakia GASTRO I. s.r.o. Presov
Slovakia Gastroenterology Department ENDOMED, s.r.o. Vranov nad Toplou
Slovenia Splosna bolnisnica Celje Celje
Slovenia Univerzitetni klinicni center Ljubljana Ljubljana
South Africa Worthwhile Clinical Trials Lakeview Hospital Benoni
South Africa Groote Schur Hospital Cape Town
South Africa Mediclinic Panorama Cape Town
South Africa Practice Dr Naeem Moosa Johannesburg
South Africa Emmed Research Pretoria
Spain Hosp Clinic de Barcelona Barcelona
Spain Hosp. Univ. La Paz Madrid
Spain Hosp. de Navarra Pamplona
Spain Hosp. Montecelo Pontevedra
Spain Corporacio Sanitari Parc Tauli Sabadell
Spain Hosp. Univ. Marques de Valdecilla Santander
Spain Hosp. Univ. de Torrejon Torrejón de Ardoz
Spain Hosp. Alvaro Cunqueiro Vigo
Sweden Karolinska Universitetssjukhuset Solna Solna
Sweden Ersta sjukhus Stockholm
Switzerland Universitatsspital Basel Basel
Switzerland Gastroenterologische Praxis Balsiger und Seibold Bern
Switzerland INSELSPITAL Universitatsspital Bern Bern
Switzerland Kantonsspital St Gallen St. Gallen
Switzerland UniversitaetsSpital Zuerich Zuerich
Taiwan China Medical University Hospital Taichung
Taiwan Taichung Veterans General Hospital Taichung
Taiwan National Cheng Kung University Hospital Tainan
Taiwan National Taiwan University Hospital, Division of Infectious Diseases Taipei
Taiwan Chang-Gung Memorial Hospital, LinKou Branch Taoyuan
United Kingdom Royal Victoria Hospital Belfast
United Kingdom Addenbrooke's Hospital Cambridge
United Kingdom Queen Elizabeth University Hospital Glasgow
United Kingdom Velocity Clinical Research High Wycombe
United Kingdom Chelsea And Westminster Hospital London
United Kingdom St George's University Hospital NHS Foundation Trust London
United Kingdom John Radcliffe Hospital Oxford
United States Valley Gastroenterology Medical Group Arcadia California
United States Atlanta Gastroenterology Associates Atlanta Georgia
United States University of Colorado Aurora Colorado
United States Washington Gastroenterology, PLLC Bellevue Washington
United States Beth Israel Deaconess Medical Center Boston Massachusetts
United States University North Carolina at Chapel Hill Chapel Hill North Carolina
United States Medical University of South Carolina Charleston South Carolina
United States Onsite Clinical Solutions Charlotte North Carolina
United States Tryon Medical Group Charlotte North Carolina
United States Brigham & Women's Hospital Chestnut Hill Massachusetts
United States Chevy Chase Clinical Research Chevy Chase Maryland
United States Pioneer Research Solutions Inc. Coconut Creek Florida
United States Peak Gastroenterology Associates Colorado Springs Colorado
United States Southern California Research Center Coronado California
United States Tri-State Gastroenterology Assoc Crestview Hills Kentucky
United States UT Southwestern Medical Center Dallas Texas
United States Gastro One Germantown Tennessee
United States Medical Research Center of Connecticut Hamden Connecticut
United States GI Specialists of Houston Houston Texas
United States Grand Teton Gastroenterology Idaho Falls Idaho
United States IU Health University Hospital Indianapolis Indiana
United States Etsu Quillen College Of Medicine Johnson City Tennessee
United States Care Access Research, Kinston Kinston North Carolina
United States Digestive and Liver Disease Institute Kissimmee Florida
United States Osceola Regional Hospital Kissimmee Florida
United States Florida Research Center Inc. Lakewood Ranch Florida
United States Om Research LLC Lancaster California
United States Care Access Las Vegas Las Vegas Nevada
United States Las Vegas Medical Research Las Vegas Nevada
United States Dartmouth Hitchcock Lebanon New Hampshire
United States University of Kentucky Chandler Medical Center Lexington Kentucky
United States Cedars Sinai Medical Center Los Angeles California
United States Jewish Hospital Louisville Kentucky
United States Gastroenterolgy Associates of Central GA Macon Georgia
United States Atlanta Gastroenterology Associates Marietta Georgia
United States Gastrointestinal Specialists of Georgia Marietta Georgia
United States Great Lakes Gastroenterology Research, LLC Mentor Ohio
United States University of Miami Miami Florida
United States Medical College Of Wisconsin Milwaukee Wisconsin
United States Gastroenterology Group Of Naples Naples Florida
United States Vanderbilt University Medical Center Nashville Tennessee
United States Gastroenterology of Southern Indiana New Albany Indiana
United States Yale University New Haven Connecticut
United States Lenox Hill Hospital New York New York
United States Weill Cornell Medical College New York New York
United States Omega Research Consultants Orlando Florida
United States Medical College Of Virginia Hospital Richmond Virginia
United States Digestive Disease Associates Rock Hill South Carolina
United States Gastroenterology Consultants Roswell Georgia
United States Synergy Clinical Research Saint Petersburg Florida
United States Gastroenterology Clinic Of San Antonio P A San Antonio Texas
United States University of California San Francisco San Francisco California
United States Swedish Medical Center Seattle Washington
United States Virginia Mason Medical Center Seattle Washington
United States Texas Digestive Disease Consultants Southlake Texas
United States Digestive Health Specialists Tacoma Washington
United States GCP Clinical Research Tampa Florida
United States Tyler Research Institute, LLC Tyler Texas
United States Frontier Clinical Research Uniontown Pennsylvania
United States Mohawk Valley Endoscopy Center Utica New York
United States MedStar Georgetown University Hospital Washington District of Columbia

Sponsors (1)

Lead Sponsor Collaborator
Janssen Research & Development, LLC

Countries where clinical trial is conducted

United States,  Argentina,  Australia,  Austria,  Belgium,  Brazil,  Bulgaria,  Canada,  Chile,  China,  Croatia,  Czechia,  Denmark,  Estonia,  France,  Germany,  Greece,  Hungary,  India,  Israel,  Italy,  Japan,  Jordan,  Korea, Republic of,  Netherlands,  New Zealand,  Norway,  Poland,  Portugal,  Slovakia,  Slovenia,  South Africa,  Spain,  Sweden,  Switzerland,  Taiwan,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Participants with Clinical Remission at Week 48 Percentage of participants with clinical remission at Week 48 will be reported. Clinical remission based on the modified Mayo subscores. Week 48
Secondary Percentage of Participants with Endoscopic Improvement at Week 48 Percentage of participants with endoscopic improvement at Week 48 will be reported. Endoscopic improvement at Week 48 based on the Mayo endoscopic subscore. Week 48
Secondary Percentage of Participants with Symptomatic Remission at Week 48 Percentage of participants with symptomatic remission at Week 48 will be reported. Symptomatic remission at Week 48 based on stool and rectal bleeding symptoms. Week 48
Secondary Percentage of Participants with Combination of Histological Remission and Endoscopic Improvement at Week 48 Percentage of participants with combination of histological remission and endoscopic improvement at Week 48 will be reported. Histologic remission and endoscopic improvement at Week 48 based on the histologic grading and the Mayo endoscopy subscore. Week 48
Secondary Percentage of Participants with Clinical Remission at Week 24 Percentage of participants with clinical remission at Week 24 will be reported. Clinical remission based on the modified Mayo subscores Week 24
Secondary Percentage of Participants with Adverse Events (AEs) An AE is any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product. An AE does not necessarily have a causal relationship with the intervention. Up to Week 48
Secondary Percentage of Participants with Serious Adverse Events (SAEs) A SAE is any untoward medical occurrence that at any dose: results in death; is life-threatening; requires inpatient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability/incapacity; is a congenital anomaly/birth defect; is a suspected transmission of any infectious agent via a medicinal product; is medically important. Up to Week 48
Secondary Serum Concentrations of Guselkumab Over Time Serum concentrations of guselkumab over time will be reported. Serum samples will be analyzed to determine concentrations of guselkumab using a validated, specific, and sensitive method. Up to Week 48
Secondary Serum Concentrations of Golimumab Over Time Serum concentration of golimumab over time will be reported. Serum samples will be analyzed to determine concentrations of golimumab using a validated, specific, and sensitive method. Up to Week 48
Secondary Percentage of Participants with Antibodies to Guselkumab Percentage of participants with antibodies to guselkumab will be reported. Up to Week 48
Secondary Titers of Antibodies to Guselkumab Titers of antibodies to guselkumab will be reported. Up to Week 48
Secondary Percentage of Participants with Antibodies to Golimumab Percentage of Participants with Antibodies to golimumab will be reported. Up to Week 48
Secondary Titers of Antibodies to Golimumab Titers of antibodies to golimumab will be reported. Up to Week 48
Secondary Percentage of Participants with Neutralizing Antibodies to Guselkumab Percentage of participants with neutralizing antibodies to guselkumab will be reported. Up to Week 48
Secondary Percentage of Participants with Neutralizing Antibodies to Golimumab Percentage of participants with neutralizing antibodies to golimumab will be reported. Up to Week 48
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04989907 - A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland
Completed NCT03494764 - Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares Phase 2
Recruiting NCT03937609 - TITRATE (inducTIon for acuTe ulceRATivE Colitis) Phase 4
Completed NCT00503243 - Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis Phase 3
Completed NCT03606499 - Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
Completed NCT02537210 - Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis N/A
Active, not recruiting NCT02316678 - Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics N/A
Completed NCT00488631 - An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis Phase 3
Completed NCT00928681 - A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis Phase 1
Completed NCT01036022 - Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis Phase 2
Recruiting NCT03841045 - Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases
Active, not recruiting NCT05528510 - A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis Phase 3
Completed NCT02825914 - CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM) N/A
Recruiting NCT06049017 - A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis Phase 2
Completed NCT04567628 - Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes
Withdrawn NCT05999708 - A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants Phase 1
Recruiting NCT05611671 - A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC Phase 2
Active, not recruiting NCT03596645 - A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis Phase 3
Completed NCT03648541 - BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis Phase 2
Completed NCT02840721 - Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis. Phase 2